Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

344 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-09-06

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a retrospective chart review of patients who underwent a hematopoietic stem cell transplant (HSCT) between 1994 and 2016 to evaluate incidence of malglycemia and the relationship to specific outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Malglycemia Via Continuous Glucose Monitoring in the Pediatric HSCT Population

NCT03037671

Hematopoietic Stem Cell Transplantation

COMPLETED

Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies

NCT02338479

Acute Lymphoblastic Leukemia/Lymphoma Myelodysplasia Acute Myelogenous Leukemia +2 more

UNKNOWN

Impact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell Transplantation

NCT03402776

Haemopoietic Stem Cell Transplantation Allograft

UNKNOWN PHASE3

Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

NCT06704542

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION Diabetes Mellitus Impaired Fasting Glucose

NOT_YET_RECRUITING

Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant

NCT00674882

Hematopoietic Stem Cell Transplantation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a retrospective chart review of patients who underwent a hematopoietic stem cell transplant between 2007 and 2016 to evaluate incidence and risk factors of malglycemia. The review will also aim to characterize relationships between specific outcomes and malglycemia in pediatric HSCT patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stem Cell Transplant Complications Hyperglycemia Hypoglycemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

With Malglycemia

Hematopoietic Stem Cell Transplant

Intervention Type PROCEDURE

Allogeneic and autologous stem cell transplants covering both malignant and non-malignant diagnoses.

Without Malglycemia

Hematopoietic Stem Cell Transplant

Intervention Type PROCEDURE

Allogeneic and autologous stem cell transplants covering both malignant and non-malignant diagnoses.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hematopoietic Stem Cell Transplant

Allogeneic and autologous stem cell transplants covering both malignant and non-malignant diagnoses.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 0 to 30 years old at time of transplant
* Bone Marrow Transplant (BMT) recipient at Children's Hospital Colorado (CHCO) between 1/1/2007 and 7/31/2016